NDC 0378-8260 – Methylphenidate
Methylphenidate 1.1 mg/h · Patch · Transdermal
Product NDC0378-8260
Product details
- Brand name
- Methylphenidate
- Generic name
- Methylphenidate
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Patch
- Route
- Transdermal
- Marketing category
- ANDA · ANDA206497
- Marketed since
- June 27, 2022
- Marketing end
- April 30, 2027
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Methylphenidate 1.1 mg/h
Uses, dosage, side effects and warnings for Methylphenidate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0378-8260-93 | 30 POUCH in 1 CARTON (0378-8260-93) / 1 PATCH in 1 POUCH (0378-8260-16) / 9 h in 1 PATCH | Jun 27, 2022 |
Other Methylphenidate products
- 0378-8261 Methylphenidate 1.6 mg/h · Patch · Mylan Pharmaceuticals Inc.
- 0378-8262 Methylphenidate 2.2 mg/h · Patch · Mylan Pharmaceuticals Inc.
- 0378-8263 Methylphenidate 3.3 mg/h · Patch · Mylan Pharmaceuticals Inc.
- 10702-163 Methylphenidate Hydrochloride 5 mg/5mL · Solution · KVK-Tech, Inc.
- 10702-164 Methylphenidate Hydrochloride 10 mg/5mL · Solution · KVK-Tech, Inc.
- 0781-2361 Methylphenidate Hydrochloride 10 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2362 Methylphenidate Hydrochloride 20 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2363 Methylphenidate Hydrochloride 30 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2364 Methylphenidate Hydrochloride 40 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2383 Methylphenidate Hydrochloride 10 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2384 Methylphenidate Hydrochloride 20 mg/1 · Capsule, Extended Release · Sandoz Inc
- 0781-2385 Methylphenidate Hydrochloride 30 mg/1 · Capsule, Extended Release · Sandoz Inc